Find a company
This project will demonstrate that delivering near-patient coagulopathy diagnostics into acute care will improve efficiency of use of resources within the hospital. This project utilises the skills of NIHR Diagnostic Evidence Co-operative London (DEC) (Imperial College St. Marys Hospital) to gather stakeholder evidence and generate potential new pathways alongside economic cost modelling. Highland Biosciences Ltd (HBL) will gather expert insight and advance its technology to meet the challenge.
Managed by HBL, the project focuses on delivering new clinical approaches to the NHS whilst generating the evidence for a highly commercially attractive value proposition for a new diagnostic business.
| Project | Improving efficiency of acute care with a near-patient coagulopathy biosensor |
|---|---|
| Description |
This project will demonstrate that delivering near-patient coagulopathy diagnostics into acute care will improve efficiency of use of resources within the hospital. This project utilises the skills of NIHR Diagnostic Evidence Co-operative London (DEC) (Imperial College St. Marys Hospital) to gather stakeholder evidence and generate potential new pathways alongside economic cost modelling. Highland Biosciences Ltd (HBL) will gather expert insight and advance its technology to meet the challenge. Managed by HBL, the project focuses on delivering new clinical approaches to the NHS whilst generating the evidence for a highly commercially attractive value proposition for a new diagnostic business. |
| Funding | £ 102,998 |
| Competition | Competition 11 - Improving patient flow to maximise operational efficiency in the Acute Sector |
| Competition Date | August 2016 |
| Website | http://www.highlandbiosciences.com/contact.asp |